The landscape of rare genetic disorders has been revolutionized by advances in understanding and treating Mucopolysaccharidosis (MPS) conditions. These inherited lysosomal storage diseases affect thousands of individuals worldwide, presenting complex clinical challenges that require specialized expertise and multidisciplinary care approaches. The accumulation of glycosaminoglycans in...

The Japan Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) market is poised for significant growth, with its size projected to rise from USD 78.61 million in 2024 to USD 155.79 million by 2034, reflecting a compound annual growth rate (CAGR) of 7.10% over the forecast period. This market expansion is largely driven by increased awareness, advancements...